Scientist I/II, Pre-Clinical
Company: Lexeo Therapeutics
Location: New York City
Posted on: February 18, 2026
|
|
|
Job Description:
Job Description Job Description Role Summary We are seeking a
talented, dedicated, passionate and motivated individual with
experience in the design and execution of pre-clinical
proof-of-concept in vitro and in vivo studies of genetic medicines
to join our team as Scientist I/II. The ideal candidate will have a
robust background in basic and translational research and be
proficient in planning and executing in vitro and in vivo
pre-clinical efficacy studies. They will also be capable of
managing projects, fostering collaborations with Key Opinion
Leaders (KOLs) and overseeing partnerships with vendors and
academic partners for pre-clinical studies. This is a highly
collaborative role where the successful candidate will join a
multi-disciplinary team focused on developing the next generation
of cardiac genetic medicines Primary Responsibilities Design and
execute proof-of-concept genetic medicine studies in cell lines,
primary cells, iPSC-derived cells and animal models Design and
oversee in vitro and in vivo pre-clinical studies to evaluate the
efficacy and safety of genetic medicine strategies with CROs and
external partners Develop and execute assays for in vitro and in
vivo phenotypic outcomes using next-generation sequencing (NGS),
PCR, qPCR, flow cytometry, Western blots and/or ELISA Analyze and
interpret data and present to internal and external audiences
Contribute to the scientific efforts and develop innovative
solutions by maintaining a broad understanding of the field
Required Skills and Qualifications PhD degree (in life sciences or
related discipline) and at least 2 years of industry or postdoc
experience or MS degree with at least 4 years of relevant
experience in industry or academia Extensive experience with
mammalian cell culture including primary human cells is required,
culturing of iPSCs and iPSC-derived cardiomyocytes is a plus
Technical experience in genomics and molecular and cellular biology
(NGS, PCR, qPCR, flow cytometry, Western blots, ELISA) Familiarity
with drug discovery for genetic medicines Ability to multi-task and
excel in a fast-paced environment Excellent troubleshooting,
written/verbal communication and project management skills
Proficiency with applications used for scientific data analysis
(e.g., GraphPad, MS, JMP, etc) Compensation is dependent on
qualifications and experience. About Lexeo Lexeo Therapeutics is a
clinical-stage genetic medicine company headquartered in New York
City, pioneering cardiac genetic medicine candidates to treat the
root causes of inherited cardiovascular diseases. Our lead program,
LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia
and anchors a broader pipeline addressing genetically defined
conditions such as hypertrophic and arrhythmogenic
cardiomyopathies. Backed by a strong financial foundation, Lexeo is
positioned to translate groundbreaking science into durable
clinical impact. Our work culture is a hybrid model with 2
days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting,
diverse, and enriching work environment. We may use artificial
intelligence (AI) tools to support parts of the hiring process,
such as reviewing applications, analyzing resumes, or assessing
responses. These tools assist our recruitment team but do not
replace human judgment. Final hiring decisions are ultimately made
by humans. If you would like more information about how your data
is processed, please contact us.
Keywords: Lexeo Therapeutics, Wayne , Scientist I/II, Pre-Clinical, Science, Research & Development , New York City, New Jersey